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Abstract
Takotsubo Cardiomyopathy (TTC) is a temporary heart-wall motion abnormality with the clinical presentation of a myocardial
infarction. Found predominantly in postmenopausal women, TTC most often appears with apical ballooning and mid-ventricle
hypokinesis. Often induced by an emotional or physical stress,TTC is reversible and excluded as a diagnosis in patients with acute
plaque rupture and obstructive coronary disease. The transient nature and positive prognosis of this cardiomyopathy leaves a
dilemma as to what precipitates it.This paper explores the theories of the pathogenesis of TTC including coronary artery spasm,
microvascular dysfunction, and catecholamine excess. A thorough analysis of the pathogenesis was conducted using online databases.The coronary artery spasm theory involves an occlusion of a blood vessel caused by a sudden vasoconstriction of a coronary
artery. This condition was confirmed in some patients with TTC using provocative testing, but failure to induce a coronary artery
spasm in many patients led to its dismissal as a primary pathogenic mechanism. It is however a significant occurrence in patients
with TTC and cannot be dismissed entirely.The microvascular dysfunction theory is challenged in the limited and underdeveloped
methods of testing for its presence. However, using the corrected Thrombolysis in Myocardial Infarction frame count method to
evaluate the flow of contrast in coronary arteries, researchers were able to indicate diffuse impaired coronary microcirculation in
the myocardium. The theory involving catecholamines is based on the catecholamine surge that many patients experience with
emotional or physical stressors.The stressor leads to excitation of the postsynaptic sympathetic neuron and the adrenal medulla,
stimulating an influx of norepinephrine and epinephrine and the resulting hypokinesis of the apical portion of the left ventricle.
Further research focused on this theory discovered the protective nature of estrogen against the catecholamine surge, explaining
the prevalence of TTC in post-menopausal women. Genetic research perpetuates this theory by presenting predisposed genetic
factors that prevent TTC. Analysis of the three theories found the catecholamine theory to be the most probable mechanism
behind TTC, but further research is necessary to confirm TTC pathogenesis.
Introduction
Background
The cardiovascular system encompasses the extensive network
that supplies the body with the nutrients and oxygen it needs to
function. At the center of this complex system, the heart serves
as an anatomical pump to push the blood out of its chambers and
throughout the body. The sinoatrial node stimulates the cardiac
muscle to contract periodically, and its normal rhythm can be
measured on an electrocardiogram (ECG). In the presence of
cardiac dysfunction, this test can indicate specific abnormalities
in the sinus rhythm. The left ventricle is the heart’s main pumping chamber, and a weakening or abnormality in its function can
produce severe repercussions. There are multiple causes of left
ventricular dysfunction. In the case of Takotsubo cardiomyopathy
(TTC), sources like coronary artery spasm, microvascular dysfunction, and catecholamine excess are suspected to contribute
to its pathogenesis (Komamura, et al. 2014). These theories are
evaluated and debated in many recent studies that seek to discover the likely origin and development of TTC.
The syndrome was first described in 1990 by a Japanese cardiologist which prompted its name, Takotsubo cardiomyopathy
(Sato, et al. 1990). Translated from Japanese to “octopus trap”,
takotsubo describes the shape of the left ventricle during systole in many patients suffering from TTC. Resembling its namesake’s rounded bottom and narrow neck, TTC most commonly
appears with apical ballooning and mid-ventricle hypokinesis.
TTC is also known as stress-induced cardiomyopathy, ampulla cardiomyopathy, transient left ventricular apical ballooning,
and broken heart syndrome. The latter title indicates the likely
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Figure 1. Left ventriculogram exhibiting Takotsubo. A: end-diastolic
phase; B: end-systolic phase. Here, the apex shows akinesis with
visible hypercontraction of the basal portion. C:Takotsubo, an
octopus trap. (Akashi, et al. 2008)
presence of an emotional or physical trigger that precipitates
the condition. Researchers found stressors such as the sudden
death of a loved one, anxiety over a family member’s congenital disorders, and vigorous excitation to be responsible for the
onset of TTC in some of their subjects (Tsuchihashi, et al. 2001).
There are instances where no physical or emotional stressor is
indicated and the trigger is unknown (Gianni, et al. 2006).

Epidemiology
This specific cardiomyopathy is a relatively new diagnosis with
the number of published cases growing in the past 20 years.The
condition occurs predominantly in postmenopausal women
which lends to one of the pathogenic theories of TTC regarding
lack of estrogen and its effects on catecholamine levels in the
body (Komamura, et al. 2014). A study found a 6.3-fold higher incidence of the condition in women than in men, differing
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from the usual male dominance in coronary artery diseases
(Tsuchihashi, et al. 2001). A systematic review of 14 studies
found that 88.8% of TTC patients were women, leaving significant room for a pathogenic mechanism that can explain the
specific epidemiology of TTC.

Clinical Manifestations
Takotsubo cardiomyopathy’s most common symptomatic presentation includes severe chest pain and dyspnea, resembling the
symptoms of an acute myocardial infarction (Komamura, et al.
2014). Where myocardial infarctions are generally preceded by
atherosclerosis, plaque buildup in arteries, TTC is excluded as a
diagnosis in patients that present with artery blockage or a history of obstructive coronary artery disease. A study found 90% of
its subjects without preceding conditions admitted to chest pain
or discomfort with the onset of TTC (Tsuchihashi, et al. 2001).
Serum level indication using cardiac biomarkers found creatine
kinase and troponin T to be elevated in many cases, indicating a
heart muscle abnormality. Creatine kinase expressed in cardiac
muscle is used to assay damage to the heart in various cardiac
conditions. In TTC, there is a slight elevation from the normal
22-198 IU/l (Tsuchihashi, et al. 2001).Troponin T, a cardiac protein
released when the heart muscle is damaged, is found to be similarly elevated (Gianni, et al. 2006). In 86.5% of patients with TTC,
left ventricular ejection fraction was reduced to 40.7±11.2% from
its normal 55% or higher. Studies also note increased left ventricular end-diastolic pressure in 93% of patients with this condition
(Templin, et al. 2015) (Tsuchihashi, et al. 2001).

Diagnosis
According to Heart Failure Association’s diagnostic criteria, patients need to fulfill the following specifications for their condition to be classified as TTC.The first is the presence of a wall motion abnormality involving the dyskinesis, hypokinesis or akenesis
of the left ventricle mid segments. This includes the ballooning of
the apex as it fails to contract. Echocardiograms or cardiac ventriculography can be used to identify this cardiomyopathy (Abe, et
al. 2003). In addition, TTC is indicated only in the absence of obstructive coronary disease and acute plaque rupture and can be
determined using angiographic images of the coronary arteries.
This exclusion differentiates TTC from a myocardial infarction, a
heart attack, which is caused by acute plaque ruptures and presents with similar symptoms. The third criteria for the diagnosis
includes the appearance of new, reversible sinus rhythm changes
on the patient’s ECG. Most commonly, the condition appears with
ST-segment elevation and T wave inversion (Gianni, et al. 2006).
Another criterion is the significant elevation of serum natriuretic
peptide (BNP or NT-proBNP), a blood indicator of heart failure.
Bloodwork to assess cardiac enzyme levels like Troponin T is also
used in the diagnosis of TTC. Perhaps the most important aspect of diagnosing a patient with TTC is the transient nature of

the condition. Essentially, the patient should recover full cardiac
function within a week of the acute episode. If a patient does not
recover full systolic function within 12 weeks, a different diagnosis
should be considered (Komamura, et al. 2014).
The Mayo Clinic’s diagnostic criteria includes the absence of
pheochromocytoma, a hormone releasing tumor of the adrenal
glands. If a patient presented with additional symptoms such as
sweating, tachycardia, and headaches, pheochromocytoma was
suspected (Reeder, Prasad, 2017). However, the updated conclusive criteria released by the Heart Failure Association, allows for
pheochromocytoma as a trigger for TTC in the event that it precipitates a catecholamine storm (Ansari, El-Battrawy, 2017). Mayo
Clinic also addresses the exclusion of myocarditis, inflammation
of the myocardium, as part of its diagnostic criteria. Myocarditis
involves slower recovery than TTC and can be excluded with the
absence of scarring and myocardial inflammation on cardiovascular magnetic resonance imaging (MRI). MRI also confirms the
reversible wall motion abnormalities and the quantification of the
ventricular function in a patient with suspected TTC.

Management
Due to its transient nature, TTC can often be managed by
addressing and alleviating the physical or emotional stressors
that triggered the onset of the cardiomyopathy. Although there
are not any conclusive treatments, treatments generally administered for heart failure such as beta blockers, ACE inhibitors,
and diuretics, are often administered as supportive care for
TTC patients. A possible treatment specified for older women
is estrogen administration. This was found to be beneficial in an
animal model of TTC, though clinical trials have not yet been
performed. The general prognosis of TTC is positive, but complications have occurred in many patients ranging from cardiogenic shock and left ventricular outflow tract obstruction, to
severe systolic dysfunction. Diagnosis and management of these
conditions is imperative to reduce the fatalities attributed to
TTC (De Backer, et al. 2014).

Methods
The research in this paper was compiled using the online databases, Pubmed and UpToDate, and through Touro’s online library
system for access to databases Proquest and Ebsco. Keywords
Takotsubo cardiomyopathy and Broken heart syndrome were
used in the initial research of this paper. Careful analysis of
the gathered material prompted further research using sources cited in articles on this topic. Both peer reviewed articles
and clinical studies were analyzed to evaluate the hypothesized
pathogenic mechanisms of Takotsubo cardiomyopathy.

Discussion
When evaluating the pathogenesis of TTC, researchers are
faced with various differentiating origins and pathways that TTC
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can develop from. A worldwide investigation of patients with
TTC has led to several possible theories of the cardiomyopathy
including a coronary artery spasm, catecholamine excess, and
microvascular dysfunction. While studies have produced results
that support all three theories, there is still a significant amount
of research required to determine the definitive pathogenic
mechanism of TTC.

Coronary Artery Spasm
The heart is a recipient of its own labor in its utilization of
its blood supply from the coronary arteries. In order for the
heart muscle to function, the correct amount of blood supply
in regular increments must be delivered through these arteries.
Many have hypothesized that an abnormality in this cycle is the
source of TTC in the form of a coronary artery spasm. A coronary artery spasm is a temporary contracting of the wall of the
artery that constricts blood flow and leads to decreased blood
supply to the heart muscle. The occlusion or near occlusion of
the vessel can cause decreased muscle movement in the heart
chambers that depend on the regular blood supply from the
coronary arteries.
Studies performed on patients with TTC support this theory. In one case study, a 79-year-old man was admitted to a
hospital presenting with three consecutive days of chest pain.
Echocardiography showed hyperkineses in the basal wall and
akenesis in the apex of the left ventricle. In order to locate the
source of the cardiomyopathy, doctors performed provocative
testing using ergonovine, a muscle contractant. The diagnostic
screening test induced a right coronary artery spasm and resulted in ECG changes with increased ST segment elevation
in leads II, III, and aVF. The patient’s normal left ventricle wall
motion was restored one week later, and he was subsequently
diagnosed with TTC with a pathogenesis attributed to a coronary artery spasm (Misumi, et al. 2010).
Although there are many cases of patients with TTC experiencing induced coronary artery spasm from provocative testing
using either ergonovine or acetylcholine, there are more that
have not. Many patients with TTC did not present with increased
susceptibility to ergonovine or acetylcholine in provocative
testing, and according to reports, only 30% of patients presented characteristics of a vasospasm with testing (Komamura, et
al. 2014). This research leaves a substantial gap in the coronary
artery spasm theory (Madias, 2014). Nonetheless, the presence
of coronary vasospasm in some TTC patients cannot be ignored
and this theory has therefore not been completely dismissed.

Microvascular Dysfunction
Another theory explored as a pathogenic mechanism of TTC
is microvascular dysfunction. The primary obstacle in exploring this mechanism is the limited technology available to evaluate microvascular function. One study was performed using
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the Thrombolysis In Myocardial Infarction (TIMI) frame count
technique, a quantitative, continuous variable that assesses flow
changes by counting the cineframes it takes for contrast to
reach coronary landmarks. Researchers evaluated the flow of
the left anterior descending artery, left circumflex artery, and
the right coronary artery in order to suggest diffuse impaired
coronary microcirculation in the myocardium. In 23 of the 24
patients studied, there was a slowdown in coronary microcirculation noted (Fazio, et al. 2010). A more recent assessment
pointed out that the akinesis in the left ventricles of those patients was too large of an area to be attributed to the dysfunctional microvessels’ supply (Vitale, et al. 2016). A corrected TIMI
frame count was performed and found that the flow was slower
in the left anterior descending artery and the researchers suggested this being the source of akinesis in the apex while the
base is relatively spared in TTC (Khalid, et al. 2015). However,
the combined studies do not find microvascular dysfunction to
be the primary source of TTC, but it is likely to play a role in
the etiopathogenesis.

Catecholamine Theory
The catecholamine theory is perhaps the most well developed
and significant theory of TTC. Many patients are noted to have
grossly elevated plasma catecholamine levels, measuring at two
to three times greater than in patients with myocardial infarctions and twenty times higher than normal adults (Zeb, et al.
2011). These elevations were noted of both adrenomedullary
and sympathoneurally-derived catecholamines. The adrenal
medulla releases epinephrine and norepinephrine after stress,
which activates preganglionic sympathetic nerves. In addition,
the peripheral sympathetic nerves release norepinephrine, both
of which contribute to the β-adrenergic pathway. The common
emotional or physical stressor in patients is tightly connected
with this theory in its influx of catecholamines. Researchers
concluded that the stressor induced hyperactivity of the sympathetic nervous system and prompted the release of catecholamines into the patient’s blood stream (Tarkin, et al. 2008).
The apex of the left ventricle has higher adrenoceptor density than the base, presenting location specific evidence for the
cardiomyopathy. The influx of catecholamines, both epinephrine
and norepinephrine, are directed to the β-adrenergic pathway. This pathway is specifically located at the apex of the left
ventricle, likely to produce the heart’s fight or flight response
of hypercontraction of the cardiomyocytes. The β-adrenergic
receptors in the cell membranes bind to the catecholamines
which ignites this response. The overstimulation of Gs (activator) through β2-coupling due to catecholamines can cause
apoptosis of the myocytes. The process therefore switches to
Gi (inhibitor) to protect the myocytes from further damage.
This causes a decrease in contraction and results in the hypokinesis of the apex of the left ventricle. There is serum evidence

Pathogenic Mechanisms of Takotsubo Cardiomyopathy or Broken Heart Syndrome

of slight necrosis caused by the excess catecholamine in the
minimally elevated troponin levels in patients with TTC. Studies
showed that a signaling pathway known to exhibit anti-apoptosis functions, phosphatidyl inositol 3-kinase protien kinase
B, presented increased activity. This may be the source of the
quick recovery of the myocytes. In addition to this, the transient
nature of this condition can be attributed to the inverse switch
from Gi to Gs resulting in the expeditious recovery of systolic
function in patients (Nef, et al. 2009).
Another theory on the rapid recovery of the myocytes is related to stem cells.A study using in vivo and in vitro cardiomyocytes
and cardiac stem cells found that the cardiac stem cells were
resistant to neurohumoral overstimulation. Researchers injected male Wistar rats with isoproterenol and noted left ventricle
dysfunction in the subjects. The left ventricular function began
to improve on day three post isoproterenol stimulation. β-adrenoreceptor hyperactivity from the catecholamine stimulation
leads to PKA-mediated hyperphosphorylation of the ryadonine
receptor 2, a calcium channel that mediates the release of Ca2+
from the sarcoplasmic reticulum to the cytoplasm. This hyperphosphorylation causes Ca2+ leakage which, in turn, produces
myocyte damage. The cardiac stem cells have low levels of β-adrenergic receptors and do not express ryadonine receptor 2.This
explains the resistance cardiac stem cells possess to the catecholamine overstimulation and the regeneration of cardiomyocytes
that restore normal left ventricle function (Ellison, et al. 2007).
There is research that suggests specifically local release of
catecholamines are at play in TTC. This is based on the findings in a study performed on blood samples from both the
aortic root and coronary sinus of patients with the condition.
Catecholamine concentration was found to be higher in the
coronary sinus signaling excessive local catecholamine release
from the heart (Kume, et al. 2008).
Besides for emotional stressors, catecholamine excess resulting in TTC is precipitated by other factors like acute brain injury
or treatment of respiratory distress. A study done on patients
with subarachnoid hemorrhage reports of eight patients developing TTC as a result of a brain aneurysm rupture. Researchers
theorize that at the time of the event, patients experience a
catecholamine surge which can mediate cardiopulmonary dysfunction (Franco, et al. 2010). A case report presenting a patient
with acute asthma exacerbation who was treated with β-2 agonist nebulization and intravenous aminophylline. After fourteen
hours of treatment she complained of shortness of breath and
pain in her jaw. Testing showed classic TTC with ST segment
elevation, T wave inversion, and left ventricular apical akinesia.
The treatment was immediately stopped and replaced with ipratropium nebulization and intravenous corticosteroids. After
48 hours the echocardiogram revealed full recovery. Additional
studies report that methylxanthines, the structural classification of aminophylline, stimulate the release of catecholamines

from the adrenal medulla and of norepinephrine from cardiac
β-adrenergic nerve endings (Khwaja, Tai, 2016). Another study
reports a similar case with a patient treated with nebulized
adrenaline to manage an airway obstruction. Like the previous
case study, this patient developed TTC post adrenaline treatment (Keshtkar, et al. 2016).These reports present a medication
administration that possibly caused a catecholamine surge suspected to have induced the patients’ TTC.
While the catecholamine theory is the most developed and
scientifically supported mechanism of TTC, not all patients are
found to have elevated catecholamine levels, prompting continued investigation into a definitive pathogenesis of the condition
(Tarkin, et al. 2008).

Low Estrogen Levels
The occurrence of TTC specifically in post-menopausal women
prompted the investigation of estrogen deficiency as a predisposing factor. One study demonstrated increased estrogen
serum levels in rats weakened cardiac changes in response to
immobilization stress. P44/p42 mitogen-activated protein kinase
was activated by the immobilization stress along with the upregulation of immediate early genes in the myocardium. Immediate
early genes are activated in response to cellular stimuli at the
transcription level. The study theorizes that estrogen attenuated this process and inhibited the activation of the sympathetic
nervous system by decreasing the formulation of immediate
early genes in both the brain and heart (Ueyama, 2004). In a
study published by this author more recently, it was determined
that, in response to immobilization stress, ovariectomized rats
that received estradiol did not experience a significant decrease
in left ventricular contraction. The ovariectomized exposed to
stress sans estradiol treatment did, however, experience percentage contraction reduction (Ueyama, et al. 2003). An evaluation of women with TTC found that majority of the patients
were post-menopausal and had not undergone estrogen replacement therapy. Researchers postulated that lack of estrogen
replacement therapy may predispose women to TTC (Kuo, et al.
2010). Combined, these studies propose that post-menopausal
women, who experience a deficiency of estrogen, lack a protective barrier against the development of TTC.

Genetic Predisposition and the Catecholamine
Theory
With analysis, the catecholamine theory appears problematic
because not all patients experience this cardiac dysfunction
with an emotional or physical stressor that may cause a catecholamine surge. Genetic research introduced new theories
that address this dilemma.
The apparent exclusiveness of patients who develop TTC suggests that the general population possesses a molecular mechanism that protects their cardiomyocytes from a catecholamine
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surge and prevents necrosis. Bcl2-associated athanogene 3
(BAG3) is a constituent of an autophagy pathway and one that
allows for the degradation of intracellular components. A study
found that it is expressed in response to various stressors and
is therefore theorized to promote stress resistance. The ablation of BAG3 in mice resulted in lethal cardiomyopathy shortly
postnatal. The study found that BAG3 single-nucleotide polymorphisms resulted in TTC. It introduced a novel post-transcriptional pathway that, in response to epinephrine treatment,
leads to BAG3 expression. Micro-RNAs are fundamental in
their role as repressors of messenger RNAs’ translation. The
study describes miR-371a-5p, a pathway that binds miRNA to
3’-untranslated region (3’-UTR) of the BAG3 gene. Epinephrine
induces miR-371a-5p which leads to BAG3 upregulation in
cardiomyocytes. However, this protective mechanism is lost in
patients who possess a single nucleotide variant involving the
3’-UTR in the BAG3 gene which alters the miR-371a-5p pathway and eliminates its binding. This genetic variant of BAG3 is
found in many patients with TTC and could explain the cardiac
dysfunction post catecholamine (D’avenia, et al. 2015).
Further research into the catecholamine mechanism produced an underlying theory involving another genetic role in
TTC. The study concluded that genetic susceptibility involving
β-adrenergic signaling increased the risk of toxicity induced by
catecholamines in TTC.
Researchers utilized technology involving the reprogramming
of somatic cells into induced pluripotent stem cells (iPSC) to
produce this conclusion. Reprogramming somatic cells of these
patients allowed for differentiation into cardiomyocytes that
could be experimented on.
The study involved healthy donors for controls and patients
with TTC. The somatic cells of the Takotsubo patients were
reprogrammed and expanded into high quality iPSC clones.
Using Wnt modulation and metabolic selection, cells were then
differentiated into cardiomyocytes (CMs). After three months,
the iPSC-CMs were subjected to isoprenaline or epinephrine
in order to replicate the catecholamine stimulation suspected
to be experienced in patients with TTC. After analysis, studies
showed that the catecholamine excess in the TTC iPSC-CMs
was apparent in the increased expression of NR4A1, a cardiac
stress-related gene. Compared to the control iPSC-CMs, the
TTC iPSC-CMs recorded much greater expression of NR4A1
post subjection to catecholamines. Three weeks after catecholamine administration, there was a reversal in changes to the
NR4A1 expression.
The researchers proceeded to investigate β-adrenergic signaling using the TTC iPSC-CMs.They measured cAMP levels and
PKA activation by phosphorylation and found increased levels
in both compared to the control iPSC-CMs after catecholamine
treatment. In addition, extracellular signal-regulated kinase
was phosphorylated maximally in the TTC iPSC-CMs after
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epinephrine or isoprenaline treatment where the controls were
significantly reduced in comparison. Increased lipid accumulation was also noted in catecholamine treated TTC iPSC-CMs.
Researchers examined the electrical activity of catecholamine
treated iPSC-CMs from patients with TTC and found that more
than half were silenced under certain isoprenaline concentrations where only some of the controls were. For those that
were not silenced, beating frequency was significantly increased
in the TTC iPSC-CMs in comparison to the control subjects.
The changes to the electrical activity was reversed following
washout of the isoprenaline after 24 hours.
Additionally, the study found that engineered heart muscles
using the TTC iPSC-CMs presented an impaired force of contraction. Muscles also presented a higher sensitivity compared
to control subjects to isoprenaline-stimulated inotropy, an altering of the force of muscle contractions. Further investigation
into the genetic makeup of the patients with TTC found variants
in some patients’ genes that are key regulators of cardiac function. These findings may contribute to the hypothesis of a predisposition to TTC, specifically involving catecholamine toxicity
(Borchert, et al. 2017).

Conclusion
The pathogenesis of TTC is an evolving phenomenon with developing theories.While coronary artery spasm is found in some
patients with TTC, the majority failed to experience induced
coronary artery spasm with provocative testing. Microvascular
dysfunction is a challenge to evaluate, but it has been found
to be a contributing factor in many patients with TTC, though
it is likely not the primary cause. Of the three theories presented, the catecholamine excess theory, supported by genetic
research, and the estrogen deficiency theory is the most well
developed pathogenic mechanism. In order to understand this
cardiomyopathy in its entirety and to produce an appropriate
treatment, more research is required involving integration of
the cardiovascular, central neural, autonomic, and endocrine systems in their response to stress, and the genetic predisposition
to TTC.
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